AP Scorecard
July 16, 2025AP Scorecard
July 17, 2025News
News
July 17, 2025
Attorney General Pam Bondi Dismisses Justice Department’s Top Ethics Lawyer
Attorney General Pam Bondi terminated the head of the Department of Justice’s (DOJ’s) ethics division, according to a letter posted to social media by the fired official.
“Pursuant to Article II of the United States Constitution and the laws of the United States, your employment with the Department of Justice is hereby terminated, and you are removed from federal service effective immediately,” the letter states.
The notice further states that Tirrell has the right to appeal the government’s decision through the U.S. Merit Systems Protection Board within 30 days.
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
Zuckerberg, Former Meta Leaders Face $8 Billion Trial Over Facebook Privacy Practices
Meta Platforms CEO Mark Zuckerberg and other high-ranking current and former executives of the company are on trial as they face accusations from shareholders of failing to safeguard user data properly.
On July 16, a non-jury trial concerning Facebook and its privacy practices began before Chief Judge Kathaleen McCormick in Delaware’s Court of Chancery. The founder of the popular social media site and other executives face allegations that they did not properly safeguard Facebook user data, leading to a record fine of $5 billion levied by the Federal Trade Commission (FTC), and billions more in related costs.
The $8 billion shareholder derivative lawsuit seeks to hold Zuckerberg, former Facebook Chief Operating Officer Sheryl Sandberg, former Facebook Vice President Konstantinos Papamiltiadis, and other directors personally liable for what plaintiffs say are breaches of their fiduciary duties.
FTC Finally DROPS HAMMER on Gender Clinics
The Federal Trade Commission, under the new Trump administration, has just catapulted the controversial world of pediatric gender medicine into the national spotlight. On July 9, 2025, the FTC convened a workshop in Washington, D.C., openly questioning whether providers of gender-affirming care have crossed the line into outright consumer fraud. The agency’s stated focus: “unfair or deceptive trade practices” in the marketing and provision of puberty blockers, hormones, and surgeries to children and teenagers.
- The FTC held its first-ever workshop investigating deceptive practices in gender-affirming care for minors, following a Trump executive order ending federal support for such procedures.
- Testimony from detransitioners, whistleblowers, and parents painted a picture of profit-driven clinics downplaying irreversible risks and overselling benefits to vulnerable youth and families.
- FTC Chairman Andrew Ferguson signaled swift enforcement, not slow bureaucracy, if evidence of fraud is confirmed—while the DOJ launched subpoenas into clinics for fraud and false statements.
- The workshop has kicked off a historic federal crackdown that could reshape how “gender medicine” operates in the United States and set new legal precedents for consumer protection in healthcare.
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||

